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concern in inferior MI with beta-blockers. In contrast ivabradine
lowers heart rate with a lesser risk of AV blocks.
Aim: To investigate the feasibility, tolerability, and the efﬁcacy of
ivabradine versusmetoprolol in acute inferior STEMI and during 30
days of follow-up.
Methods: It's a prospective double blind single centre randomized
controlled study. Of 1032 patients with acute inferior STEMI, 564
patients did not fulﬁll the inclusion criteria andwere excluded. 468
patients were included in the study and were randomized in 1:1
manner to ivabradine (group A) and metoprolol (group B). 42
patients were lost on follow up and excluded. Per protocol analysis
of 426 patients (group A – 210 and group B – 216) was done. The
primary end point was 30-day incidence of MACE including death,
nonfatal MI, complete heart block (CHB) and heart failure. Second-
ary endpoints included 30 day incidence of recurrent angina, read-
mission, ﬁrst or second degree AV block and tachyarrhythmias.
Results: Both the drugs decreased themean heart rate 62.22  2.95
(group A) vs 62.53  3.59 (group B) beats per minute ( p = 0.33).
Ejection fraction improved in both the groups. The two groups
did not differ signiﬁcantly in their primary endpoints in terms of
death (group A = 1.90% vs group B = 1.85%, OR = 1.03, 95% CI = 0.25–
4.17, p = 0.97), reinfarction (group A = 0.95% vs group B = 0.93%,
OR = 1.03, 95% CI = 0.14–7.37, p = 0.98), heart failure (group
A = 4.76% vs group B = 2.78%, OR = 1.75, 95% CI = 0.62–4.90,
p = 0.29) or CHB (0% vs 2.78%, OR = 0.08, 95% CI = 0.004–1.37
p = 0.08). There were no signiﬁcant differences in the secondary
end points of recurrent angina, readmission and NSVT but sig-
niﬁcantly more ﬁrst degree AV blocks occurred with metoprolol
(13.89% vs 2.86%, OR = 5.48, 95% CI = 2.23–13.47, p = 0.0002).
Conclusions: Ivabradine is equally effective as metoprolol in acute
inferior wall STEMI patients for lowering the heart rate with less
risk of CHB.
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Background: ‘‘Coronary slow ﬂow’’ (CSF) is delayed vessel opaci-
ﬁcation in the absence of epicardial stenosis and is characterized
by decreased coronary ﬂow velocity. Studies in different ethnic
groups have found variable risk factors associatedwith CSF. Aim of
present study was to analyse the risk factors and angiographic
proﬁle of CSF in North Indian population which has not been
studied till date.
Methods: 30 patients with CSF and 30 age and sex matched con-
trols without CSF have been studied till date (study is ongoing).
Coronary ﬂow patterns were determined quantitatively by throm-
bolysis in myocardial infarction (TIMI) frame count method. CSF
was deﬁned as TIMI frame count more >27 frames at frame rate of
30 frames per second. Various clinical risk factors (age, sex, dia-
betes, hypertension, dyslipidemia, smoking), hematological and
biochemical parameters (hemoglobin, hematocrit, platelet count,
erythrocyte sedimentation rate (ESR), blood urea, serum creati-
nine, uric acid, homocysteine, ﬁbrinogen, high sensitivity C reac-
tive protein (hsCRP), HbA1C were compared between the two
groups.
Results: Of the 30 patients with CSF, 28 (93%) were males. While 15
patients (50%) presented with chronic stable angina, rest 15 (50%)
presented with acute coronary syndrome. [10 (33%) with unstable
angina and 5 (17%) with non ST elevation myocardial infarction
(NSTEMI)]. 9 patients had CSF in all 3 vessels (30%), 17 had CSF in 2
vessels (57%) and 4 had CSF in 1 vessel (13%). The most common
artery involved was left anterior descending (LAD) [n = 27 (90%)],
followed by left circumﬂex (LCX) [n = 23 (77%)] and right coronary
artery (RCA) [n = 13 (43%)]. Patients with CSF had signiﬁcantly
elevated ESR (16.50  15.75 vs. 6.13  4.72 mm/hr, p = 0.001), ﬁbri-
nogen (393.77  130.87 vs. 307.93  168.44, p = 0.03) and serum
creatinine (393.77  130.87 vs. 307.93  168.44, p = 0.03). No signiﬁ-
cant differences in other risk factors were observed.
Conclusion: This is the ﬁrst study to analyse clinical presentation,
risk factors and angiographic proﬁle associated with CSF in North
Indian population. In this study we found CSF was signiﬁcantly
associated with male sex, raised ESR, elevated ﬁbrinogen and
creatinine.
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Background: Primary percutaneous coronary intervention (PPCI) is
the reperfusion therapy of choice among patients with STEMI
owing to a low risk of reinfarction and improved survival rates.
Thrombolysis is important as ‘‘the appropriate and timely use of
reperfusion therapy is likely to be more important than the choice
of therapy’’. Primary Percutaneous Coronary Intervention after
thrombolysis to achieve TIMI 3/2 ﬂow in the affected epicardial
vessel is a prerequisite for optimal myocardial reperfusion. Pri-
mary PCI is recognized as the best strategy for treatment of
patients for whom it is applicable.
Method: 150 patients were screened and 140 underwent diagnostic
angiography within 24 hours after thrombolysis. Full dose of
thrombolizing agent were used for acute STEMI patients if PCI
was delayed to ≥30 min. Patients were recommended to undergo
diagnostic angiography within 3–24 h after thrombolysis. Patient
with residual stenosis ≥70% in the infarct related artery underwent
PCI. Epicardial arterial ﬂow was assessed using TIMI ﬂow grade.
Result:Out of 150 Patients, 72wereAcute IWMI, 78were AWMI. Out
of 140 patients, 100 patients underwent PCI, 17 patients were
medically managed, and 23 patients underwent CABG. Out of
100 Plasty, 78 had single vessel and 22 had double vessel disease.
TIMI ﬂow before and after PCI (n = 100).
The composite end point of death cardiogenic shock occurred in 2
patients. No TIMI major bleeding & stroke occurred. No patient
needed emergency CABG.
Conclusion: These results support the routine implementation of
an early invasive strategy after successful thrombolization in this
population, with a trend towards a further reduction of reinfarc-
tion and death/reinfarction in higher risk STEMI patients. Use of
thrombolizing agent is still an important option for reperfusion in
many.
n TIMI ﬂow (Before PCI) n TIMI ﬂow (After PCI)
4 TIMI 0 2 TIMI 0
10 TIMI 1 4 TIMI 1
25 TIMI 2 4 TIMI 2
61 TIMI 3 90 TIMI 3
i n d i a n h e a r t j o u rn a l 6 7 ( 2 0 1 5 ) s 1 2 1 – s 1 3 3 S127
